TITLE

Travellers' diarrhoea: causes, prevention and treatment

AUTHOR(S)
Lloyd, Rhoswen; Bennett, Clare
PUB. DATE
June 2012
SOURCE
Nursing Standard;6/6/2012, Vol. 26 Issue 40, p51
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article describes the prevention and treatment of travellers' diarrhoea, the leading cause of illness in people travelling abroad. The most common cause of travellers' diarrhoea worldwide is bacterial pathogens, which account for up to 80% of cases. Exercising caution over dietary selection and personal hygiene is the most common method used for reducing the risk of acquiring travellers' diarrhoea. Antibiotics, probiotics, prebiotics and bismuth subsalicylate have all been indicated for the prevention of this distressing condition. Treatments include antimotility agents, oral rehydration salts and antibiotics.
ACCESSION #
76444532

 

Related Articles

  • PROBIOTICS IN DIARRHEA: MYTHS AND FACTS. Qureshi, Absar A.; Omer, Shaista; Kumar, K. Eswar; Bhajipale, N. S. // International Journal of Pharmacy & Pharmaceutical Sciences;2010 Supplement, Vol. 2 Issue S3, p23 

    Diarrhea is a common health problem worldwide. Antibiotics, nosocomial infections and microorganism are the common factors responsible for diarrhea. Moreover, imbalance in intestinal microbial flora also leads to diarrhea. Probiotics is a living microorganism administered to promote the health...

  • Rifaximin: A Novel Nonabsorbed Rifamycin for Gastrointestinal Disorders. Adachi, Javier A.; DuPont, Herbert L. // Clinical Infectious Diseases;2/15/2006, Vol. 42 Issue 4, p541 

    Rifaximin, a virtually nonabsorbed (<0.4%) rifamycin drug, has in vitro activity against aerobic and anaerobic gram-positive and gram-negative microorganisms. Because rifaximin is nonabsorbed, systemic adverse effects are unusual, and after 3 days of therapy, the fecal level of the drug reaches...

  • ATYPICAL BACTERIAL PATHOGENS IN THE INTESTINAL TRACT. Breidenbach, Warren C.; Martin, Alison // American Journal of Gastroenterology;Nov1961, Vol. 36 Issue 5, p513 

    Presents information on the atypical bacterial pathogens in the intestinal tract. Characteristics of the bacteria in the intestinal tract; Analysis of several patients with intestinal bacteria; Type of drug used to treat intestinal bacteria.

  • Looking for Evidence that Personal Hygiene Precautions Prevent Traveler's Diarrhea. Shlim, David R. // Clinical Infectious Diseases;12/2/2005, Vol. 41, pS531 

    In the 50 years during which traveler's diarrhea has been studied, it has always been assumed that personal hygiene precautions can prevent or reduce the likelihood of developing traveler's diarrhea. However, 7 of 8 studies that specifically addressed this issue showed no correlation between the...

  • Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice. Skinn, Andrew C.; Vergnolle, Nathalie; Zamuner, Stella R.; Wallace, John L.; Cellars, Laurie; MacNaughton, Wallace K.; Sherman, Philip M. // Canadian Journal of Physiology & Pharmacology;Dec2006, Vol. 84 Issue 12, p1301 

    Attaching-effacing bacteria are major causes of infectious diarrhea in humans worldwide. Citrobacter rodentium is an attaching-effacing enteric pathogen that causes transmissible murine colonic mucosal hyperplasia. We characterized colonic inflammation and ion transport at 3, 7, 10, 30, and 60 d...

  • Pathogen-Specific Risk Factors and Protective Factors for Acute Diarrheal Illness in Children Aged 12--59 Months in São Paulo, Brazil. Sobel, J.; Gomes, T A. T.; Ramos, R. T S.; Hoekstra, M.; Rodrigue, D.; Rassi, V.; Griffin, P. M. // Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1545 

    Diarrheal diseases are a leading cause of childhood morbidity and mortality in Latin America. Most studies have focused on infants but not on older children. We enrolled 505 children (age, 12-59 months) with diarrhea and age-matched controls in a case-control study in São Paulo, Brazil....

  • Strategies to Reduce the Devastating Costs of Early Childhood Diarrhea and Its Potential Long-Term Impact: Imperatives that We Can No Longer Afford to Ignore. Lima, Aldo A. M.; Guerrant, Richard L. // Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1552 

    This article focuses on strategies to reduce the devastating costs of early childhood diarrhea and its potential long-term impact. Although risk and protective factors may vary with local environments, host factors, and specific pathogens involved in acute diarrheal illnesses, cost-effective...

  • TO SCOPE OR NOT TO SCOPE: THE ROLE OF ENDOSCOPY IN THE EVALUATION OF AIDS- RELATED DIARRHEA. Johanson, John F. // American Journal of Gastroenterology;Nov1996, Vol. 91 Issue 11, p2261 

    Comments on the role of endoscopy in the evaluation of AIDS-related diarrhea. Percentage of all AIDS patients who will develop diarrhea at some point in the course of their disease; Reason behind the debate surrounding the diagnosis of AIDS-related diarrhea; Example of a risk factor for AIDS...

  • A parallel diagnostic accuracy study of three molecular panels for the detection of bacterial gastroenteritis. Biswas, J.; Al-Ali, A.; Rajput, P.; Smith, D.; Goldenberg, S. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2014, Vol. 33 Issue 11, p2075 

    Culture-dependent detection of gastroenteric bacteria is labour-intensive and does not provide results in a clinically relevant time frame. Several commercially available multiplex molecular panels are now available which may be more sensitive and could potentially provide rapid results. We...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics